Prostate-Specific Antigen (PSA): Clinical Applications in Prostate Cancer Staging

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Tumor Markers (retired 12/7/2020). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tumor Markers (retired 12/7/2020) (online CE course)
Prostate-Specific Antigen (PSA): Clinical Applications in Prostate Cancer Staging

You may recall that one of the desired characteristics of an ideal tumor marker is to correlate with tumor mass and degree of metastasis. In this respect, PSA serves as an effective tool to help assess the stage of prostate cancer. Higher PSA levels strongly correlate with tumor mass and metastasis. PSA levels greater than 50 µg/L are highly indicative of an advanced stage of prostate cancer. Similarly, patients with PSA levels less than 20 µg/L seldom have bone metastases.2